Cosmos Health Inc (COSM) Stock Analysis
Verdict: AVOID
Surging revenue and insider buys clash with acute cash burn, $15.98M debt, and NASDAQ delisting risk under $1.00.
Investment score: 35/100
Analysis as of
Is Cosmos Health Inc stock worth reviewing? The TradeMates thesis
TradeMates views Cosmos Health as a high-risk micro-cap where solid top-line growth is offset by persistent cash drain, low gross margins, and delisting overhang.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 20/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 85/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
Cosmos Health Inc opportunities and risks
What speaks for COSM
- Contract manufacturing orderbook growth at Cana Laboratories
What speaks against COSM
- Acute cash runway constraint and imminent dilution risk
Frequently asked questions about Cosmos Health Inc (COSM)
Is COSM stock a good investment?
The TradeMates model rates Cosmos Health Inc as AVOID with an investment score of 35/100. TradeMates views Cosmos Health as a high-risk micro-cap where solid top-line growth is offset by persistent cash drain, low gross margins, and delisting overhang. This is algorithmic model output, not personal investment advice.
Is COSM stock a buy?
The TradeMates model verdict for COSM is AVOID with an investment score of 35/100. Treat this as a model signal to review, not a personal buy recommendation.